Study of Fibrinogen Metabolism During Severe Trauma and Burns

NCT ID: NCT00588796

Last Updated: 2015-02-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2005-02-28

Study Completion Date

2014-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To study the fibrinogen metabolic changes in relation to coagulation disorder in patients with severe burns and trauma injuries. As a result of the burn or trauma injury breakdown of fibrinogen is accelerated.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this protocol, we will investigate fibrinogen metabolism in burn and trauma patients, using an 8h infusion of stable isotopes labeled amino acids (1-13C-phenylalanine, 2H5-phenylalanine, and 2H3-ketoisocaporate). The increase of the labeled amino acids incorporating into fibrinogen during the infusion and the decay of labeled fibrinogen after stopping the isotopes infusion (as measured by GC-MS) will be used to calculate fibrinogen synthesis and degradation. Stable isotopes are non-radioactive.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Burn Injury Major Trauma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy Volunteers

Healthy Volunteers

No interventions assigned to this group

Burn patients

Patients who have sustained burn injury greater than or equal to 20% of total body surface area

No interventions assigned to this group

Trauma patients

Patients who have undergone trauma

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 20% total body surface area burn or more
* severe trauma with injury severity score greater than 10
* between ages of 18 and 65 years

Exclusion Criteria

* history of blood clotting disorder
* history of liver disease such as cirrhosis or hepatitis
* pregnant or nursing
* allergic to iodine, shellfish or dye used in X-Rays
* taking long term medications for blood clotting usch as Coumadin or Plavix
* prisoners
* receiving total parenteral nutrition
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

United States Army Institute of Surgical Research

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Wenjun Z Martini, PhD

Role: PRINCIPAL_INVESTIGATOR

United States Army Institute of Surgical Research

References

Explore related publications, articles, or registry entries linked to this study.

Zuckerman L, Caprini JA, Lipp V, Vagher JP. Disseminated intravascular multiple systems activation (DIMSA) following thermal injury. J Trauma. 1978 Jun;18(6):432-9. doi: 10.1097/00005373-197806000-00008.

Reference Type BACKGROUND
PMID: 660699 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H-04-017

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

SN514-066b Enzyme in Deep Partial Thickness Burns
NCT06628037 ENROLLING_BY_INVITATION PHASE1/PHASE2
Albumin Use in Burn Patients
NCT00609414 COMPLETED
Prospective Case Registry for Wounds
NCT05898698 ACTIVE_NOT_RECRUITING
Large Burn Outcome Study
NCT00731887 WITHDRAWN